WMA
GILD icon

West Michigan Advisors’s Gilead Sciences GILD Stock Holding History

West Michigan Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.99M Buy
39,458
+9,662
+32% +$1.27M 0.95% 25
2026
Q1 		$4.15M Buy
29,796
+3,091
+12% +$433K 0.91% 24
2025
Q4 		$3.28M Buy
26,705
+4,173
+19% +$507K 0.75% 32
2025
Q3 		$2.5M Buy
22,532
+18,264
+428% +$2.08M 0.6% 47
2025
Q2 		$473K Sell
4,268
-1,439
-25% -$153K 0.13% 117
2025
Q1 		$639K Buy
+5,707
New +$589K 0.21% 80
2022
Q1 		– Sell
-5,352
Closed -$389K – 135
2021
Q4 		$389K Buy
+5,352
New +$369K 0.29% 67

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

West Michigan Advisors's GILD Position: Q2 2026 in Review

West Michigan Advisors increased its Gilead Sciences (GILD) stake by 32% in Q2 2026, buying an estimated $1.27M and bringing the position to 39,458 shares worth $4.99M. The position accounts for 0.95% of the portfolio, ranked #25.

West Michigan Advisors first reported a position in GILD in Q4 2021 and has held it in 7 quarters since. 2,284 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • West Michigan Advisors held 39,458 shares of Gilead Sciences worth $4.99M as of Q2 2026.
  • West Michigan Advisors bought 9,662 Gilead Sciences shares in Q2 2026, an estimated $1.27M.
  • Gilead Sciences made up 0.95% of West Michigan Advisors's portfolio in Q2 2026, its #25 holding.
  • West Michigan Advisors first reported a position in Gilead Sciences in Q4 2021 and has held it in 7 quarters since.
  • 2,284 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on West Michigan Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.